UA104460C2 - Anti-fcrh5 antibodies and immunoconjugates and methods of use - Google Patents

Anti-fcrh5 antibodies and immunoconjugates and methods of use

Info

Publication number
UA104460C2
UA104460C2 UAA201112795A UAA201112795A UA104460C2 UA 104460 C2 UA104460 C2 UA 104460C2 UA A201112795 A UAA201112795 A UA A201112795A UA A201112795 A UAA201112795 A UA A201112795A UA 104460 C2 UA104460 C2 UA 104460C2
Authority
UA
Ukraine
Prior art keywords
methods
immunoconjugates
fcrh5 antibodies
fcrh5
antibodies
Prior art date
Application number
UAA201112795A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Крісті Елкінс
Ендрю Полсон
Аллен Ебенс
Камелія Адамс
Бін Чжен
Джагатх Р. ДЖУНУТУЛА
Джо-Енн Хонго
Янь У
Original Assignee
Дженентек, Інк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дженентек, Інк. filed Critical Дженентек, Інк.
Priority claimed from PCT/US2010/029516 external-priority patent/WO2010120561A1/en
Publication of UA104460C2 publication Critical patent/UA104460C2/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention is directed to antibodies specific for FcRH5, to compositions comprising said antibodies useful for the treatment of hematopoietic tumors in mammal and to methods of using said compositions for said purpose.
UAA201112795A 2009-04-01 2010-03-31 Anti-fcrh5 antibodies and immunoconjugates and methods of use UA104460C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21169509P 2009-04-01 2009-04-01
PCT/US2010/029516 WO2010120561A1 (en) 2009-04-01 2010-03-31 Anti-fcrh5 antibodies and immunoconjugates and methods of use

Publications (1)

Publication Number Publication Date
UA104460C2 true UA104460C2 (en) 2014-02-10

Family

ID=56266318

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201112795A UA104460C2 (en) 2009-04-01 2010-03-31 Anti-fcrh5 antibodies and immunoconjugates and methods of use

Country Status (1)

Country Link
UA (1) UA104460C2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2748943C2 (en) * 2015-06-16 2021-06-02 Дженентек, Инк. HUMANIZED ANTIBODIES AND ANTIBODIES WITH MATURE AFFINITY AGAINST FcRH5 AND METHODS FOR THEIR APPLICATION

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2748943C2 (en) * 2015-06-16 2021-06-02 Дженентек, Инк. HUMANIZED ANTIBODIES AND ANTIBODIES WITH MATURE AFFINITY AGAINST FcRH5 AND METHODS FOR THEIR APPLICATION

Similar Documents

Publication Publication Date Title
TW200942551A (en) Anti-CD79b antibodies and immunoconjugates and methods of use
PH12020550741A1 (en) Anti-cd79b antibodies and immunoconjugates and methods of use
MX2019000225A (en) Compositions and methods for treatment of autoimmune and other disease.
IL206970A0 (en) Compositions and methods for the treatment of tumor of hematopoietic origin
IN2012DN02046A (en)
MX2011010390A (en) Polymer-agent conjugates, particles, compositions, and related methods of use.
CL2013000016A1 (en) Compounds derived from imidazopyridine; preparation procedure; Pharmaceutical composition and its use in the treatment of cancer.
WO2011106297A3 (en) Compositions and methods for the diagnosis and treatment of tumor
MX359639B (en) METHODS and COMPOSITIONS FOR USE IN CELLULAR THERAPIES.
UA103004C2 (en) Humanized anti-cd79b antibodies and immunoconjugates and methods of use
EA201490636A1 (en) T-CELLS DESIGNED WITH THE HELP OF RNA FOR THE TREATMENT OF MALIGNOUS NON-FORMATIONS
TN2012000161A1 (en) Spiro-oxindole mdm2 antagonists
MX2012009088A (en) Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor.
EA201071320A1 (en) АКТИВАТОРЫ ГЛЮКОКИНАЗЫ
MY160041A (en) Compositions and methods for treating parasitic infections
EA201390660A1 (en) MODIFIED NICOTINE COMPOUNDS AND RELATED METHODS
MX2007016322A (en) Compositions and methods for the diagnosis and treatment of tumor.
WO2012024530A3 (en) Therapeutic peptide-polymer conjugates, particles, compositions, and related methods
EA201390993A1 (en) ANTIBODIES TO CD38
EA201370018A1 (en) COMPOSITIONS OF RIFAXIMINE AND THEIR APPLICATION
EA201200999A1 (en) METHODS OF TREATMENT BREAST CANCER
EA201170288A1 (en) OXABICYCLOPTANES AND OXABICYCLOPTENS
PH12016500047A1 (en) Antibodies for treating and diagnosing tumors expressing slc34a2 (tat211-seqid2)
EA201171435A1 (en) SOLID PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR PRODUCTION
IN2014DN09228A (en)